Share:
Peer-Reviewed Publication
J Diabetes Sci Technol2026;20(1):227-228.January 1, 2026Letter

iCoDE-2 September 18, 2025 Steering Committee Final Meeting Summary Report.

Agatha F Scheideman1, Mandy M Shao1, Simona Carini2, Viral N Shah3, Alaina P Vidmar4, Sarah D Corathers5, Eric Williams6, Lawrence Lett6, Mark Clements7, David C Klonoff8, Juan Espinoza6
1Diabetes Technology Society, Burlingame, CA, USA.
2Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
3Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, IN, USA.
4Center for Endocrinology, Diabetes and Metabolism, Department of Pediatrics, Children's Hospital Los Angeles and Keck School of Medicine of University of Southern California, Los Angeles, CA, USA.
5Division of Endocrinology, Cincinnati Children's Hospital Medical Center, University of Cincinnati, College of Medicine, Cincinnati, OH, USA.
6Stanley Manne Children's Research Institute, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
7Glooko Inc., Palo Alto, CA, USA.
8Diabetes Research Institute, Mills-Peninsula Medical Center (Sutter Health), San Mateo, CA, USA.

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.